Biological feature of matrix metalloproteinase and its action in metastasis of liver cancer

World Chinese Journal of Digestology

Volumn 8, Issue 12, 2000, Pages 1403-1404

  Jiang, Z S ^a   Gao, Y ^a  

^a NONE

Author keywords

Blotting, western; Extracellular matrix; Immunohistochemistry; In site hybridization; Liver neoplasms; Matix metalloproteinases; Neoplasm metastasis

Indexed keywords

MATRIX METALLOPROTEINASE; MITOGEN ACTIVATED PROTEIN KINASE; TISSUE INHIBITOR OF METALLOPROTEINASE;

EXTRACELLULAR MATRIX; HUMAN; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LIVER CANCER; METASTASIS; PATHOGENESIS; REVIEW; WESTERN BLOTTING;

EID: 0034493313     PISSN: 10093079     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (31)

1. Increased type IV collagen-degrading activity in metastases originating from primary tumors of the human colon
2. Elevated plasma levels of matrix metallo-proteinase-9 (92-kd type IV collagenase/gelatinase B) in hepatocellular carcinoma
3. Elevated levels of serum and plasma metallo proteinases in patients with gastric cancer
4. Exogenous expression of N-cadherin in breast cancer cells induces cell migration, invasion, and metastasis
5. Detection of matrix metalloproteinase activity in human pancreatic cancer
6. TGF-β1 inhibits the formation of benign skin tumors, but enhances progression to invasive spindle carcinomas in transgenic mice
7. TNF-R55-specific form of human tumor necrosis factor-α induces collagenase gene expression by human skin fibroblasts
8. Regulation of matrix metalliproteinase expression in tumor invasion
9. Loss of basement membrane type IV collagen is associated with increased expression of metalloproteinases 2 and 9 (MMP-2 and MMP-9) during human colorectal tumorigenesis
10. Processing of a precuesor of 72-Kilodalton tapy IV collagenase/gelatinase A by a recombinant membrane-type I matrix metalloproteinase
11. Measurement of matrix metalloproteinases and tissue inhibitors of metalloproteinases in blood and tissues. Clinical and experimental applications
12. Differential expression and origin of membrane-type 1 and 2 matrix metalloproteinases (MT-MMP) in association with MMP-2 activation in injured human livers
13. Effects of matrix metalloproteinase inhibitor BB-94 on liver cancer growth and metastasis in a patient-like orthotopic model LCI-D20
14. Implication of VEGF and MMPs in hepatic metastasis of human colon cancer
15. Regulation and significance of hepato cytederived matrix metalloproteinases in liver remodeling
16. In situ detection of matrix metalloproteinase-2 (MMP-2) and the metalloproteinase-2 inhibitor (TIMP-2) transcripts in human primary hepatocellular carcinoma and in liver metastasis
17. Relation of ehanced secretion of active matrix metalloproteinases with tumor spead in human hepatocellular carcinoma
18. Overexpression of matrix metalloproteinase-9 gene in hepatocellular carcinoma with invasive potential
19. Unique activation of matrix metalloproteinase-9 with human liver metastasis from colorectal cancer
20. In vitro determination of basement membrane invasion predicts liver metastases in human gastrointestinal carcinoma
21. Expression of immunoreactive matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in human normal livers and primary liver tumors
22. Matrix metalloproteinase inhibition prevents colon cancer peritoneal carcinomatosis development and prolongs survival in rats
23. Phase I study of intrapleural batimastat (BB-94), a matrix metalloproteinase inhibitor, in the treatment of malignant pleural effusions
24. The matrix metalloproteinase inhibitor batimastat inhibits angiogenesis in liver metastases of B16F1 melanoma cells
25. Elevated plasma levels of matrix metalloproteinase-9 in hepatocellular carcinoma